NEUROMUSCULAR DISEASES (NMD)
Clinical trials for NEUROMUSCULAR DISEASES (NMD) explained in plain language.
Never miss a new study
Get alerted when new NEUROMUSCULAR DISEASES (NMD) trials appear
Sign up with your email to follow new studies for NEUROMUSCULAR DISEASES (NMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for duchenne: targeted drug trial aims to slow muscle decline
Disease control Not yet recruitingThis study tests an experimental drug called AOC 1044 (delpacibart zotadirsen) in 70 boys aged 7 to 16 with Duchenne muscular dystrophy who have a specific genetic change (exon 44 skipping). The drug is given through a vein and aims to improve muscle function, such as how fast th…
Matched conditions: NEUROMUSCULAR DISEASES (NMD)
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Foot surgery or just therapy? new study aims to settle the debate for CMT patients
Knowledge-focused Not yet recruitingThis study looks at 200 people with Charcot-Marie-Tooth disease (CMT) who have foot problems that make walking hard. It compares two treatments: foot surgery followed by rehabilitation, versus physical therapy alone. Researchers will track walking speed and endurance for up to tw…
Matched conditions: NEUROMUSCULAR DISEASES (NMD)
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC